Linshom
Private Company
Total funding raised: $1.8M
Overview
Linshom Medical, founded in 2015 and based in San Francisco, is a private medical device company pioneering continuous predictive respiratory monitoring. Its core product is a non-invasive, wearable monitor that delivers high-fidelity respiratory rate, breath timing, and relative tidal volume trends, primarily for patients on oxygen masks. The technology aims to provide early warning of respiratory depression, potentially preventing rapid response events, ICU transfers, and deaths. The company is FDA-cleared and appears to be in the early commercial or early revenue stage, targeting post-operative and general floor patient monitoring.
Technology Platform
Wearable, non-invasive sensor system (Continuous Predictive Respiratory Monitor - CPRM) that provides operating room-quality respiratory data (Respiratory Rate, Seconds Since Last Breath, trend of Relative Tidal Volume) continuously at the bedside.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competition includes large patient monitoring companies (e.g., Medtronic, GE Healthcare, Philips) whose traditional capnography and respiratory monitors are often bulky and designed for ICUs/ORs. A growing number of startups are developing wearable patches for vital sign monitoring, some of which include respiratory rate, but few claim the specific tidal volume trend capability for masked patients that Linshom emphasizes.